Cedric Francois

Chief Executive Officer

Cedric Francois (Chief Executive Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in APLS. The largest single filing was $592K of APLS (27,192 sh × $21.77, as filed), executed Jan 22.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$980K

shares × price, as filed

Last traded

Jan 22

Filed Jan 23

Open performance→

Volume by month

Buys $0 Sells $11.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 3 filings

Sector per market data · by filing · past 12 months

Most traded names

APLS APLS APLS · 0 buys · 9 sells 9 filings

Recent filings

APLSSALE Apellis Pharmaceuticals, Inc. View filing → $592K
27,192 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $162K
8,182 sh × $19.79
Exec Jan 20
Filed Jan 21 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $226K
10,186 sh × $22.19
Exec Jan 13
Filed Jan 15 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $6.4M
225,000 sh across 2 lots
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $399K
19,725 sh × $20.21
Exec Jul 17 2025
Filed Jul 18 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $2.8M
137,465 sh × $20.19
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $412K
13,551 sh × $30.43
Exec Jan 22 2025
Filed Jan 23 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $180K
6,007 sh × $29.96
Exec Jan 17 2025
Filed Jan 21 2025 · 5:30 PM ET More filings →